Ignite Creation Date:
2025-12-25 @ 3:09 AM
Ignite Modification Date:
2025-12-26 @ 1:48 AM
Study NCT ID:
NCT05874505
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-05-25
First Post:
2023-04-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
"Comparison of the Efficacy and Safety of Adalimumab to That of Tocilizumab in Severe Uveitis of Behçet's Disease"
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-07
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-07
Completion Date Type:
ESTIMATED
First Submit Date:
2023-04-14
First Submit QC Date:
None
Study First Post Date:
2023-05-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-15
Last Update Post Date:
2023-05-25
Last Update Post Date Type:
ACTUAL